PMID- 9202370
OWN - NLM
STAT- MEDLINE
DCOM- 19970717
LR  - 20190622
IS  - 0002-9149 (Print)
IS  - 0002-9149 (Linking)
VI  - 79
IP  - 12
DP  - 1997 Jun 15
TI  - Serum levels of soluble form of Fas molecule in patients with congestive heart 
      failure.
PG  - 1698-701
AB  - Compared with soluble Fas molecule (sFas, an inhibitor of Fas-mediated apoptosis) 
      in normal volunteers, the serum level of sFas significantly increased by 41% in 
      New York Heart Association (NYHA) class III (p <0.05) and by 97% in NYHA class IV 
      patients with congestive heart failure (p <0.001). Furthermore, sFas showed 
      correlations with soluble forms of TNF receptor-p55 (RI) and -p75 (RII) (r = 0.68 
      and r = 0.56) which inhibit activities of TNF alpha.
FAU - Okuyama, M
AU  - Okuyama M
AD  - The First Department of Internal Medicine, Yamagata University Medical School, 
      Japan.
FAU - Yamaguchi, S
AU  - Yamaguchi S
FAU - Nozaki, N
AU  - Nozaki N
FAU - Yamaoka, M
AU  - Yamaoka M
FAU - Shirakabe, M
AU  - Shirakabe M
FAU - Tomoike, H
AU  - Tomoike H
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Am J Cardiol
JT  - The American journal of cardiology
JID - 0207277
RN  - 0 (Receptors, Tumor Necrosis Factor)
RN  - 0 (fas Receptor)
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Female
MH  - Heart Failure/*blood/classification/etiology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Molecular Weight
MH  - Receptors, Tumor Necrosis Factor/blood
MH  - fas Receptor/*blood
EDAT- 1997/06/15 00:00
MHDA- 1997/06/15 00:01
CRDT- 1997/06/15 00:00
PHST- 1997/06/15 00:00 [pubmed]
PHST- 1997/06/15 00:01 [medline]
PHST- 1997/06/15 00:00 [entrez]
AID - S0002914997002282 [pii]
AID - 10.1016/s0002-9149(97)00228-2 [doi]
PST - ppublish
SO  - Am J Cardiol. 1997 Jun 15;79(12):1698-701. doi: 10.1016/s0002-9149(97)00228-2.